Breaking AI & Tech News Analyzed

President Donald Trump signed an executive order on Saturday in the Oval Office, joined by podcaster Joe Rogan, to fast‑track the federal review of psychedelic drugs such as ibogaine, aiming to broaden treatment options for serious mental illness.The ceremony highlighted Rogan’s long‑standing advocacy for ibogaine, a plant‑derived compound used by some veteran groups to address post‑traumatic stress. Rogan recounted texting Trump about the drug, to which the president replied, “Sounds great. Do you want FDA approval? Let’s do it.”Trump framed the order as a lifeline for patients: “Today’s order will ensure that people suffering from debilitating symptoms might finally have a chance to reclaim their lives and lead a happier life.” He added that successful outcomes could have “a tremendous impact.”In a brief moment of levity, Trump joked, “Can I have some, please? I’ll take some.” He quickly refocused, noting he has no time for depression and stays busy instead.The move enjoys rare bipartisan backing, despite ibogaine and other psychedelics remaining classified under the federal government’s most restrictive drug schedule.Health Secretary Robert F. Kennedy Jr. had previously pledged to ease medical access to psychedelics, a stance echoed in the new order, which directs the Department of Health and Human Services to allocate at least $50 million to states developing programs for serious mental‑health conditions.Simultaneously, the FDA is set to issue “national priority” vouchers for three psychedelic candidates. Commissioner Marty Makary said the vouchers will enable rapid approval “if they align with our national priorities.”The agency also plans the first human trials of ibogaine in the United States, overcoming earlier concerns about potential fatal heart effects.Ibogaine’s origins trace back to the Bwiti religious ceremonies in West‑Central Africa, where the plant has been used for centuries in spiritual contexts.Former Navy SEAL Marcus Luttrell, also present at the event, praised ibogaine, stating, “It absolutely changed my life for the better.”Rogan’s endorsement and the executive order have added a new dimension to Trump’s 2024 campaign narrative, even as he has publicly questioned the administration’s stance on the war with Iran.

The conflict that erupted in April 2023 between Sudan’s army and the Rapid Support Forces has driven the country’s humanitarian situation to catastrophic levels, according to the international non‑governmental organisation Humanity & Inclusion.Three years on, the NGO warns that civilians are enduring a deepening crisis, while people with disabilities are confronting extreme challenges as violence continues, essential services crumble, and unexploded ordnance spreads across former battle zones.Humanity & Inclusion estimates that 11.6 million Sudanese have been displaced by the fighting, and that **more than 33 million people now require humanitarian assistance**—roughly half the nation’s population. By the end of January 2026, over **3 million displaced individuals had begun returning home**, including **700,000 who had fled abroad**. Most of these returns have been to states where hostilities have eased, such as Khartoum, the Blue Nile and Gezira regions.The organisation highlights that **4.6 million Sudanese—about 16 % of the total population—live with disabilities**. In conflict‑affected areas this proportion is likely higher due to war‑related injuries, trauma, and deteriorating health conditions. The NGO stresses that disabled persons “face extreme challenges in fleeing violence, accessing aid, and protecting themselves from harm,” and are often among “the first to be left behind,” exposing them to heightened risks of violence, abuse, discrimination and exclusion.Adding to the peril, Humanity & Inclusion points to the lingering presence of **explosive remnants of war**, describing them as a “new and deadly danger” for millions returning to their homes. Unexploded ordnance—including antipersonnel mines—has contaminated former front lines, residential areas, schools, hospitals, places of worship and roadways, severely restricting access to essential services and livelihoods.These findings underscore the urgent need for intensified humanitarian response, targeted protection measures for people with disabilities, and comprehensive clearance of explosive hazards to prevent further civilian casualties and enable the safe return of displaced populations.

Scientists have made a groundbreaking discovery, identifying a distinct 'neural fingerprint' produced by psychedelic drugs in the human brain when users experience their mind-altering effects.This breakthrough finding emerged from a comprehensive study that combined 11 brain imaging datasets from around the world, involving over 500 brain scans from 267 people in five countries. The research focused on five psychedelic substances: LSD, psilocybin, DMT, mescaline, and ayahuasca.The study revealed that these substances have a shared impact on the brain's behavior, dissolving the usual hierarchy of brain systems and flattening the hierarchy, which may underlie the raw access to one's own consciousness that some people describe during psychedelic experiences.Dr. Danilo Bzdok, a senior author on the study from McGill University in Montreal, Canada, explained that all five drugs change brain function in common ways, despite some differences in how they alter brain activity. The most striking effect was stronger communication between brain networks that engage in higher-level thinking and more primitive networks linked to vision and sensation.The research, published in Nature Medicine, provides a solid foundation for psychedelic research, which is crucial if these drugs are to become widespread therapies for mental health conditions such as depression, schizophrenia, and post-traumatic stress disorder.Dr. Emmanuel Stamatakis, a senior co-author on the study from the University of Cambridge, emphasized the importance of large-scale, coordinated evidence in the field of psychedelic research, which is moving quickly and needs to mature responsibly.

In England, 1 in 15 adults now hold blue badge parking permits, a significant increase that has raised concerns about the misuse of these permits. The blue badge scheme, which allows people with disabilities or health conditions to park closer to shops and services, has seen a substantial rise in the number of permits issued. According to the latest data from the Department for Transport (DfT), 3.07 million blue badges were held as of March 31 last year, with more than 6% of the estimated 46 million adults in England holding one. This represents a significant increase, with the proportion of adults holding blue badges rising to 1 in 15. The AA has called for councils to crack down on the misuse of blue badge permits, including the use of fake or stolen badges. The organization estimates that up to 1 in 5 badges may be used by someone other than the holder or authorized user. This misuse can include family misuse, use after death, counterfeit badges, and theft and resale of badges. The issue of blue badge misuse has significant financial implications, with the estimated cost of blue badge fraud in the UK being £46m per year in 2011. While there are no recent figures for the cost of blue badge fraud, it is likely that the issue remains a significant concern. In response to the issue, councils have reported prosecutions for blue badge misuse in recent months. For example, Croydon council in south London reported that seven offenders were ordered to pay a total of nearly £6,000 in fines, court costs, and a victim surcharge. Oxfordshire county council also reported two blue badge misuse convictions, including a man caught using his dead grandmother's badge. The Local Government Association has emphasized the importance of residents reporting suspected cases of blue badge misuse to help councils tackle the issue. A DfT spokesperson has also stated that exploitation and abuse of the blue badge scheme is completely unacceptable and a criminal offence, and that local authorities have been given improved powers to crack down on fraud and misuse.

The tragic case of Oliver Robinson, a 34-year-old who took his own life in November 2023, has sparked a campaign for stricter controls on private cannabis clinics in the UK. An inquest concluded that Robinson's prescription for medicinal cannabis, issued by Curaleaf Clinic, probably contributed to his death and acted as an obstacle to him receiving proper psychiatric and addiction care. Robinson had been struggling with depression and addiction, and had been treated at the Priory, a private mental health facility. He was initially prescribed medicinal cannabis in May 2022, which initially provided relief but ultimately worsened his condition. The coroner's report highlighted several failings in his care, including the use of an out-of-date GP summary care record and incomplete information in prescribing decisions. Alexander Robinson, Oliver's brother, is now advocating for tighter regulation of private cannabis clinics, including a ban on prescribing to patients with serious mental illness and greater oversight of the rapidly expanding industry. He believes that the current safeguards are not strong enough to protect vulnerable psychiatric patients. The UK government reported about 5,000 NHS prescriptions for licensed cannabis-based medicinal products in 2023, while freedom of information data showed that 659,293 unlicensed cannabis products were privately prescribed in 2024, more than double the number issued in 2023. Critics argue that there is limited evidence that cannabis is an effective treatment for depression and other common mental health conditions. Dr. Pavan Chahl, an expert psychiatrist, told Oliver's inquest that medicinal cannabis should not have been prescribed to someone with a history of severe psychiatric disorder, citing a lack of evidence for efficacy in depression and the risk of worsening symptoms. In response to the campaign, Curaleaf Clinic stated that it would engage constructively with any review or consultation aimed at strengthening patient safety across the sector.

Chinese dissident artist Gao Zhen, renowned for his satirical sculptures of Mao Zedong, has been tried in China on charges of 'defaming national heroes and martyrs'. His wife and a human rights group reported the trial.Gao, 69, was detained in 2024 during a visit to China from the US. He faces a maximum three-year prison sentence. The trial took place behind closed doors in Hebei province and ended without a verdict.Gao is known for his sculptures criticizing the 1966-1976 Cultural Revolution, a period of social turmoil and political persecution in China. His works include 'Miss Mao', featuring Mao with a Pinocchio nose and breasts, and 'Mao's Guilt', a bronze statue of Mao kneeling remorsefully.Gao's wife, Zhao Yaliang, and their seven-year-old son, a US citizen, are under exit bans and cannot leave China. Gao suffers from malnutrition and various health conditions, including lumbar spine disease and chronic knee and eye conditions.The trial highlights China's strict control over artistic expression and its efforts to suppress dissent. EU diplomats attempted to attend the trial but were blocked from entering the court.

Female athletes are on the verge of a major breakthrough in insurance coverage, addressing critical gaps in support for pregnancy, contraception, menopause, and health conditions that disproportionately affect women. This development stems from the Carney review, an independent assessment of women's football led by former England international Karen Carney.The Women's Football Taskforce, established by the government to implement the Carney review's recommendations, has collaborated with Loughborough University and leading insurance providers to ensure female athletes receive appropriate insurance coverage. Loughborough University, ranked the world's No. 1 university for sports-related subjects for a 10th consecutive year, played a pivotal role in driving these changes.The changes aim to address 'blind spots' in insurance policies, particularly concerning pregnancy, contraception, menopause, and conditions like Relative Energy Deficiency in Sport (Red-S), a complex syndrome caused by low energy availability. Red-S can lead to metabolic, hormonal, and physiological changes, with indicators such as stress fractures and disruptions to the menstrual cycle.Karen Carney praised the development, stating, “Seeing the recommendations being taken seriously and resulting in tangible improvements is always amazing.” She emphasized the importance of the report and thanked those involved in making these changes a reality.Stephanie Peacock, the minister for sport and chair of the Women's Football Taskforce, welcomed the positive change, highlighting the collaborative effort with insurers and Prof Jo Maher of Loughborough University.The British Insurance Brokers’ Association is working with major brokers like Aon, Willis, and Marsh to revise policies. Aon has already extended its personal accident policies to include miscarriage as a result of a sporting accident as standard. Axis and Association for British Insurers are also reviewing their products to better support female athletes.Prof Jo Maher noted, “Developing products for female athletes marks an important step in ensuring we drive world-class and equitable standards in women’s sport.” She emphasized the collaborative effort to level the playing field and support the growing success of women's sports.

The UK's retail industry is bracing for the impact of reforms to guaranteed working hours, which could affect over half of retail jobs. The British Retail Consortium (BRC) has warned that the changes, set to take effect from April, may make it harder for shops to employ people, particularly young workers, in part-time roles. The Employment Rights Act will introduce new protections for workers on sick pay, sexual harassment, parental leave, and trade union recognition. Additionally, the act will provide rights to guaranteed hours for those on zero or 'low hours' contracts, flexible working, payment for short-notice cancellation of shifts, and barring fire-and-rehire practices in most circumstances. The BRC, representing major UK retailers, suggests that guaranteed hours protections should only apply to contracts of eight hours a week or fewer, and the reference period to be at least 26 weeks – or ideally a full year. This, they argue, would better reflect seasonal working patterns and ensure reforms address genuine problems without undermining jobs. Helen Dickinson, the chief executive of the BRC, emphasized that flexible retail jobs are vital for millions of people, providing opportunities for students, parents, and those managing health conditions. She warned that if reforms treat flexibility as a problem rather than something workers actively choose, the risk is fewer opportunities and reduced access to work. The BRC noted that 55% of retail roles are part-time, significantly above the UK average of 33%. A survey of 2,000 adults by Opinium for the BRC found that 52% of UK adults think the ability to flex working hours around their lives is important. However, the shop workers' union Usdaw and the TUC have expressed support for the reforms, arguing that they will deliver benefits to those in insecure employment, particularly women and disabled workers, and provide greater job security and predictability for working people.